Renal Cell Carcinoma Journal Articles

• COVID-19 Pandemic Impacts on Treatment for Metastatic Cancer The COVID-19 pandemic has resulted in delays and disruptions in health care. Has it similarly affected the treatment of patients with metastatic cancer?
  Journal of the National Cancer Institute, May 04, 2022
• Management of Pheochromocytomas and Paragangliomas The perioperative management of these rare neuroendocrine tumors requires a multidisciplinary approach. Find out what there is to know.
  Journal of the Endocrine Society, March 08, 2022
• Molecular Alterations and Immune Checkpoint Blockade Could certain genomic biomarkers predict response or resistance to immune checkpoint inhibitor treatment?
  Journal of the National Cancer Institute, January 11, 2022
• Diagnostic Workup, Etiology of Hypercalcemia of Malignancy Could new research challenge current thinking about the etiology of hypercalcemia of malignancy?
  Journal of the Endocrine Society, December 02, 2021
• Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA A new analysis investigates the potential for patients with rheumatoid arthritis to experience adverse events after treatment with immune checkpoint inhibitors.
  Journal of Clinical Rheumatology, November 01, 2021
• Management of Thyrotoxicosis Induced by PD1 or PDL1 Blockade Thyrotoxicosis is an immune-related adverse event associated with PD1 and PD-L1 blockade therapy. How is this condition best managed?
  Journal of the Endocrine Society, September 06, 2021
• Second- and Later-Line Treatment of Metastatic RCC When first-line treatments for metastatic renal cell carcinoma fail, what are the next options?
  Current Opinion in Urology, July 19, 2021
• Prevalence and Outcome of COVID-19 in Cancer Patients How susceptible are cancer patients to COVID-19, and how might the infection impact outcomes?
  Journal of the National Cancer Institute, June 30, 2021
• Immune Checkpoint Blockade in Brain Metastases This review explores the workings of the immune system in the brain and the immunology of brain metastases. Might immune checkpoint inhibitors be efficacious in the treatment of these tumors?
  Brain, June 15, 2021
• Cardiotoxicity of Immune Checkpoint Inhibitors A new study found a much higher frequency of cardiac events in cancer patients receiving immune checkpoint inhibitors compared to those receiving non-ICI therapy.
  European Heart Journal, May 28, 2021
• Incident Type 2 Diabetes Duration and Cancer Risk A new study finds that type 2 diabetes may be associated with an increased cancer risk, highlighting the potential role of hyperinsulinemia in cancer development.
  Journal of the National Cancer Institute, May 27, 2021
• Cancer Incidence Among American Indian and Alaska Natives This study highlights cancers with elevated incidence among American Indian and Alaska Native populations compared with Whites, revealing important health disparities between the groups.
  American Journal of Epidemiology, May 04, 2021
• Risk Stratification of Adrenal Masses By (18F)FDG PET/CT Learn more about the role of 18F-FDG-PET/CT in the malignancy risk stratification of adrenal masses.
  Clinical Endocrinology, February 19, 2021
• Association of Hepatitis C Infection and Risk of Kidney Cancer Do patients with hepatitis C have a significantly higher risk of developing kidney cancer?
  Journal of Viral Hepatitis, February 11, 2021
• An Atypical Presentation of Multiple Primary Malignancies Gastric carcinoma is the neoplasm most commonly associated with second primary neoplasms. This case underscores the need to consider multiple primary malignancy in patients with gastric cancer.
  Journal of Medical Case Reports, February 10, 2021
• Cabozantinib Caused High-grade Fever in Metastatic RCC This case demonstrates atypical high-grade fever with rigors as a potential complication of treatment with the novel tyrosine kinase inhibitor cabozantinib.
  Journal of Medical Case Reports, December 30, 2020
• Clinical Applications of AI in Urologic Oncology Learn more about the potential role of AI in the diagnosis and management of urologic malignancies.
  Current Opinion in Urology, December 17, 2020
• Epidemiology, Clinical Presentation, and Evaluation of UTUC What do we currently know about the epidemiology, presentation, and assessment of upper-tract urothelial carcinoma?
  Translational Andrology and Urology, November 23, 2020
• Cancer Prevention and Screening for Older Adults This review addresses special considerations regarding prevention and early identification of lung, colorectal, bladder, and kidney cancer for adults aged 65 and older.
  Journal of the American Geriatrics Society, November 18, 2020
• PET Imaging in Urology: A Successful Collaboration Learn more about the diagnostic and therapeutic role of positron emission tomography in the field of urological oncology.
  Current Opinion in Urology, October 16, 2020